Standalone PDPs vs. Medicare Advantage: The Growing Disparity

The changing economics of Medicare Part D created a stark divide between standalone Prescription Drug Plans (PDPs), which pair with Original Medicare, and Medicare Advantage plans with prescription drug coverage (MA-PDs). Understanding this structural difference explains why standalone plans are getting hit much harder by premium increases.

Standalone Part D plans rely entirely on drug plan premiums and direct federal risk adjustments to cover costs. Because these plans only manage prescription benefits, they have no other revenue streams to absorb high specialty drug claims. As a result, standalone PDP options are shrinking across the country, and their average monthly premiums continue to climb.

In contrast, Medicare Advantage plans integrate medical coverage (Parts A and B) with prescription drug coverage (Part D). Medicare Advantage insurance carriers receive substantial federal capitation payments and medical rebates for managing a member’s full care. If an MA-PD plan manages hospitalizations and routine doctor care efficiently, it can use surplus medical rebates to subsidize its prescription drug operations. This cross-subsidization allows Medicare Advantage sponsors to maintain $0 or low-cost monthly premiums even as drug liability increases.